Absci Exec Bedrick Todd Sees Long‑Term Upside, Grabs 15,000 RSUs Amid Rising Insider Buying Surge
Absci insider Bedrick Todd’s 15,000‑share RSU purchase signals executive confidence in its synthetic‑biology platform, hinting at potential upside for investors.
3 minutes to read